UBS Group
HCA icon

UBS Group’s HCA Healthcare HCA Stock Holding History

UBS Group’s Portfolio HCA Stock Details HCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14M Sell
35,900
-300
-0.8% -$127K ﹤0.01% 3070
2026
Q1 		$17.1M Sell
36,200
-32,700
-47% -$16.5M ﹤0.01% 2766
2025
Q4 		$32.2M Buy
68,900
+1,300
+2% +$604K 0.01% 2099
2025
Q3 		$28.8M Sell
67,600
-26,000
-28% -$10.1M ﹤0.01% 2173
2025
Q2 		$35.9M Sell
93,600
-57,000
-38% -$20.5M 0.01% 1814
2025
Q1 		$52M Sell
150,600
-110,500
-42% -$35.5M 0.01% 1450
2024
Q4 		$78.4M Sell
261,100
-64,000
-20% -$22.4M 0.01% 1078
2024
Q3 		$132M Buy
325,100
+119,900
+58% +$43.9M 0.03% 592
2024
Q2 		$65.9M Buy
205,200
+70,900
+53% +$23M 0.02% 862
2024
Q1 		$44.8M Buy
134,300
+2,800
+2% +$856K 0.01% 1109
2023
Q4 		$35.6M Buy
131,500
+31,000
+31% +$7.66M 0.01% 1194
2023
Q3 		$24.7M Buy
100,500
+92,300
+1,126% +$25.3M 0.01% 1318
2023
Q2 		$2.49M Sell
8,200
-49,400
-86% -$13.7M ﹤0.01% 3321
2023
Q1 		$15.2M Sell
57,600
-25,500
-31% -$6.48M 0.01% 1592
2022
Q4 		$19.9M Buy
83,100
+8,200
+11% +$1.84M 0.01% 1411
2022
Q3 		$13.8M Buy
74,900
+39,400
+111% +$7.85M 0.01% 1532
2022
Q2 		$5.97M Sell
35,500
-17,500
-33% -$3.76M ﹤0.01% 2223
2022
Q1 		$13.3M Sell
53,000
-71,600
-57% -$18M ﹤0.01% 1726
2021
Q4 		$32M Buy
124,600
+100,600
+419% +$24.6M 0.01% 1250
2021
Q3 		$5.83M Buy
24,000
+4,000
+20% +$978K ﹤0.01% 2509
2021
Q2 		$4.13M Hold
20,000
– – ﹤0.01% 2893
2021
Q1 		$3.77M Hold
20,000
– – ﹤0.01% 2911
2020
Q4 		$3.29M Hold
20,000
– – ﹤0.01% 2896
2020
Q3 		$2.49M Hold
20,000
– – ﹤0.01% 2852
2020
Q2 		$1.94M Buy
+20,000
New +$2.08M ﹤0.01% 2899
2016
Q2 		– Sell
-495,600
Closed -$38.7M – 7821
2016
Q1 		$38.7M Buy
+495,600
New +$34.6M 0.03% 560
2015
Q2 		– Sell
-66,200
Closed -$4.98M – 8636
2015
Q1 		$4.98M Buy
+66,200
New +$4.75M ﹤0.01% 2075

Other funds holding HCA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group's HCA Position: Q2 2026 in Review

UBS Group reduced its HCA Healthcare (HCA) stake by 7.9% in Q2 2026, selling an estimated $21.6M and leaving 592,355 shares worth $231M. The position accounts for 0.03% of the portfolio, ranked #585.

UBS Group first reported a position in HCA in Q4 2014 and has held it in 47 quarters since. The position peaked at $683M in Q3 2025. 1,340 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • UBS Group held 592,355 shares of HCA Healthcare worth $231M as of Q2 2026.
  • UBS Group sold 51,127 HCA Healthcare shares in Q2 2026, an estimated $21.6M.
  • HCA Healthcare made up 0.03% of UBS Group's portfolio in Q2 2026, its #585 holding.
  • UBS Group first reported a position in HCA Healthcare in Q4 2014 and has held it in 47 quarters since.
  • UBS Group's HCA Healthcare position peaked at $683M in Q3 2025.
  • 1,340 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.